Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
11501
PUT
Hagerty
HGTY
$1.55B
| $69.2K | ﹤0.01% |
6,800
+3,500
| +106% | +$38.8K |
2023 Q1
6 quarters
|
|
|
GURE
11502
CALL
Gulf Resources
GURE
$5.24M
| $69.1K | ﹤0.01% |
7,310
+5,430
| +289% | +$58.8K |
2023 Q4
3 quarters
|
|
11503
PUT
Cellebrite
CLBT
$2.82B
| $69K | ﹤0.01% |
4,100
+1,900
| +86% | +$28.2K |
2023 Q3
4 quarters
|
|
|
ONCY
11504
Oncolytics Biotech
ONCY
$76M
| $69K | ﹤0.01% |
79,249
-57,836
| -42% | -$56.8K |
2023 Q4
3 quarters
|
|
|
MIN
11505
Aberdeen Intermediate Income Fund
MIN
$263M
| $69K | ﹤0.01% |
25,354
+13,758
| +119% | +$37.4K |
2024 Q2
1 quarter
|
|
11506
CALL
Hycroft Mining Holding Corp
HYMC
$1.67B
| $69K | ﹤0.01% |
27,580
-7,750
| -22% | -$18.7K |
2022 Q1
10 quarters
|
|
11507
PUT
Perdoceo Education
PRDO
$2.01B
| $68.9K | ﹤0.01% |
3,100
-24,900
| -89% | -$561K |
2022 Q4
7 quarters
|
|
11508
PUT
Resources Connection
RGP
$129M
| $68.9K | ﹤0.01% |
7,100
-700
| -9% | -$7.23K |
2022 Q4
7 quarters
|
|
11509
CALL
RLX Technology
RLX
$2.11B
| $68.8K | ﹤0.01% |
38,000
+5,500
| +17% | +$9.44K |
2021 Q1
14 quarters
|
|
11510
CALL
Heartland Express
HTLD
$872M
| $68.8K | ﹤0.01% |
5,600
-16,600
| -75% | -$204K |
2022 Q4
7 quarters
|
|
11511
CALL
BRC Inc
BRCC
$135M
| $68.7K | ﹤0.01% |
2,010
+70
| +4% | +$3.21K |
2022 Q1
10 quarters
|
|
|
MREO
11512
CALL
Mereo BioPharma
MREO
$56.3M
| $68.6K | ﹤0.01% |
16,700
-11,200
| -40% | -$46.3K |
2021 Q1
14 quarters
|
|
|
FIRY
11513
PUT
Firy Inc
FIRY
$197M
| $68.6K | ﹤0.01% |
12,205
+3,600
| +42% | +$22.2K |
2020 Q3
16 quarters
|
|
|
ETHD
11514
PUT
ProShares UltraShort Ether ETF
ETHD
$65.6M
| $68.5K | ﹤0.01% |
+120
| New | +$71.6K |
2024 Q3
0 quarters
|
|
11515
CALL
Cabaletta Bio
CABA
$334M
| $68.4K | ﹤0.01% |
14,500
-4,400
| -23% | -$25.5K |
2022 Q3
8 quarters
|
|
11516
CALL
Atomera
ATOM
$171M
| $68.4K | ﹤0.01% |
26,000
+23,400
| +900% | +$72.9K |
2020 Q3
16 quarters
|
|
|
ZIMV
11517
CALL
DELISTED
ZimVie
ZIMV
| $68.2K | ﹤0.01% |
4,300
-26,500
| -86% | -$476K |
2022 Q1
10 quarters
|
|
|
CVAC
11518
CALL
DELISTED
CureVac
CVAC
| $68.2K | ﹤0.01% |
23,200
+2,000
| +9% | +$6.59K |
2020 Q3
16 quarters
|
|
|
LICY
11519
CALL
DELISTED
Li-Cycle Holdings Corp.
LICY
| $68.2K | ﹤0.01% |
31,140
+8,672
| +39% | +$23.9K |
2021 Q3
12 quarters
|
|
11520
PUT
Global X Autonomous & Electric Vehicles ETF
DRIV
$363M
| $68.1K | ﹤0.01% |
+2,900
| New | +$65.9K |
2024 Q3
0 quarters
|
|
|
KLRS
11521
Kalaris Therapeutics
KLRS
$60.9M
| $68.1K | ﹤0.01% |
3,661
-1,003
| -22% | -$17.5K |
2023 Q4
3 quarters
|
|
|
FINV
11522
CALL
FinVolution Group
FINV
$692M
| $68K | ﹤0.01% |
+11,000
| New | +$58.5K |
2024 Q3
0 quarters
|
|
11523
PUT
Schwab US Large- Cap ETF
SCHX
$75.2B
| $67.8K | ﹤0.01% |
3,000
+2,700
| +900% | +$58.8K |
2022 Q4
7 quarters
|
|
11524
PUT
Millicom
TIGO
$15.2B
| $67.8K | ﹤0.01% |
2,500
+1,400
| +127% | +$36.2K |
2024 Q1
2 quarters
|
|
11525
Microvast
MVST
$237M
| $67.8K | ﹤0.01% |
+271,546
| New | +$90.7K |
2024 Q3
0 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.